Granules India Ltd share price was up by 0.16% from the previous closing price of ₹589.30. Who are peers of Granules India Ltd? The peers of Granules India Ltd are Sun Pharmaceuticals Industries ...

US President Donald Trump announced the formation of a committee to develop a regulatory framework for digital assets, led by David Sacks. The executive order aims to advance America's crypto ...

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 14,313.19 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...

Jan 13, 2025 11:16 Lupin Gets USFDA Approval for Generic Cystic Fibrosis Treatment Lupin receives USFDA approval for its generic version of Ivacaftor oral granules, a treatment for cystic fibrosis.

Mission Statement: Evidence-based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research ...